83_FR_28549 83 FR 28431 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

83 FR 28431 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 118 (June 19, 2018)

Page Range28431-28432
FR Document2018-13138

Federal Register, Volume 83 Issue 118 (Tuesday, June 19, 2018) 
[Federal Register Volume 83, Number 118 (Tuesday, June 19, 2018)]
[Notices]
[Pages 28431-28432]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-13138]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which

[[Page 28432]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Immunity in the Elderly (R01).
    Date: July 9-10, 2018.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health LD30, 5601 Fishers Lane, 
Rockville, MD 20892.
    Contact Person: Julio Aliberti, Ph.D., Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers 
Lane, MSC-9823, Rockville, MD 20852, 301-761-7322, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Maintaining Immunity after 
Immunization (U01).
    Date: July 11-12, 2018.
    Time: 8:30 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892.
    Contact Person: Geetanjali Bansal, Ph.D., Scientific Reviewer 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G49, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9834, Bethesda, MD 20892-9834, (240) 669-5073, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID INVESTIGATOR INITIATED 
PROGRAM PROJECT (P01).
    Date: July 11, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Raymond R. Schleef, Ph.D., Senior Scientific 
Review Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3E61, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5019, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: June 13, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-13138 Filed 6-18-18; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 118 / Tuesday, June 19, 2018 / Notices 28431 TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB Date OMB Title of collection approval control No. expires Infant Formula Requirements .................................................................................................................................. 0910–0256 5/31/2021 Premarket Notification for a New Dietary Ingredient ............................................................................................... 0910–0330 5/31/2021 Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring .............................................. 0910–0409 5/31/2021 Guidance for Industry: Formal Dispute Resolution; Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice ................................................................................................................. 0910–0563 5/31/2021 Requests for Inspection by an Accredited Person Under the Inspection for Accredited Persons Program .......... 0910–0569 5/31/2021 Substances Prohibited from Use in Animal Food or Feed ..................................................................................... 0910–0627 5/31/2021 Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300 ................................................................................................................................................. 0910–0633 5/31/2021 Guidance for Industry: Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic ............................................................................................................................. 0910–0701 5/31/2021 Guidance on Consultation Procedures: Foods Derived From New Plant Varieties ............................................... 0910–0704 5/31/2021 Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices ...................... 0910–0741 5/31/2021 Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments ................................................................. 0910–0782 5/31/2021 Guidance for Industry, Researchers, Patient Groups, and Food and Drug Administration Staff on Meetings with the Office of Orphan Products Development ....................................................................................................... 0910–0787 5/31/2021 Food Allergen Labeling and Reporting .................................................................................................................... 0910–0792 5/31/2021 Transfer of a Premarket Notification Clearance ...................................................................................................... 0910–0852 5/31/2021 Dated: June 13, 2018. Amount of Non-Competitive Award: provide jurisdictions with strategies, Leslie Kux, $300,000 in FY 2018. tools, and resources to effectively Associate Commissioner for Policy. Period of Funding: July 1, 2018, allocate annual available resources to [FR Doc. 2018–13098 Filed 6–18–18; 8:45 am] through June 30, 2019. prioritize HIV unmet needs. The TA CFDA Number: No. 93.145. activities will be directed at addressing BILLING CODE 4164–01–P Authority: Sections 2606 and 2654(b) more efficient and proactive methods in of the Public Health Service Act, as the Priority Setting and Resource DEPARTMENT OF HEALTH AND amended by the Ryan White HIV/AIDS Allocation (PSRA) process to increase HUMAN SERVICES Treatment Extension Act of 2009 (Pub. the ability of health care providers and L. 111–87). systems to ensure people living with Health Resources and Services Justification: In 2016, JSI was awarded HIV are linked to care, remain engaged Administration a 3-year cooperative agreement under in care, and achieve HIV viral HRSA–16–082 RWHAP Integrated HIV suppression. Ryan White HIV/AIDS Program Parts A Planning Implementation (CFDA 93.145), authorized by Sections 2606 Dated: June 12, 2018. and B Integrated HIV Planning and 2654(b) of the Public Health Service George Sigounas, Implementation Cooperative Agreement to John Snow, Inc. (JSI), Act, as amended by the Ryan White Administrator. U69HA30144 HIV/AIDS Treatment Extension Act of [FR Doc. 2018–13121 Filed 6–18–18; 8:45 am] 2009 (Pub. L. 111–87). The cooperative BILLING CODE 4165–15–P AGENCY: Health Resources and Services agreement was established to provide Administration (HRSA), Department of technical assistance to RWHAP Parts A Health and Human Services. and B recipients and their planning DEPARTMENT OF HEALTH AND ACTION: Notice of non-competitive FY bodies regarding: (1) The integration of HUMAN SERVICES 2018 supplemental award. HIV planning across prevention, care, and treatment service delivery systems; National Institutes of Health SUMMARY: This noncompetitive and (2) the development, supplement award to JSI will support National Institute of Allergy and implementation, monitoring, and and strengthen current Ryan White HIV/ Infectious Diseases; Notice of Closed evaluation of Integrated HIV Prevention AIDS Program (RWHAP) Part A and Part Meetings and Care Plans. RWHAP Parts A and B B priority setting and resource recipients and planning bodies use Pursuant to section 10(d) of the allocation processes to ensure people Integrated Plans to better inform and Federal Advisory Committee Act, as living with HIV are linked to care, coordinate HIV prevention and care amended, notice is hereby given of the remain engaged in care, and achieve program planning, resource allocation, following meetings. viral suppression. and continuous quality improvement The meetings will be closed to the FOR FURTHER INFORMATION CONTACT: Dr. efforts to meet the HIV service delivery public in accordance with the Rene Sterling, Acting Director, Division needs within their jurisdictions. provisions set forth in sections of State HIV/AIDS Programs, HIV/AIDS The proposed supplemental funding 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., daltland on DSKBBV9HB2PROD with NOTICES Bureau, HRSA; 5600 Fishers Lane, will provide RWHAP Parts A and B as amended. The grant applications and Room 09W50, Rockville, MD 20857; recipients with additional technical the discussions could disclose Phone: (301) 443–9017, Email: assistance (TA) specifically focused on confidential trade secrets or commercial rsterling@hrsa.gov. resource allocation planning and property such as patentable material, SUPPLEMENTARY INFORMATION: implementation. These additional TA and personal information concerning Intended Recipient of the Award: JSI activities will build upon data elements individuals associated with the grant (U69HA30144). identified in the Integrated Plan and applications, the disclosure of which VerDate Sep<11>2014 17:55 Jun 18, 2018 Jkt 244001 PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1

28432 Federal Register / Vol. 83, No. 118 / Tuesday, June 19, 2018 / Notices would constitute a clearly unwarranted DEPARTMENT OF HEALTH AND DEPARTMENT OF HOMELAND invasion of personal privacy. HUMAN SERVICES SECURITY Name of Committee: National Institute of Substance Abuse and Mental Health Federal Emergency Management Allergy and Infectious Diseases Special Services Administration Agency Emphasis Panel; Immunity in the Elderly (R01). [Docket ID FEMA–2018–0002; Internal Date: July 9–10, 2018. Notice of Meeting Agency Docket No. FEMA–B–1830] Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant Pursuant to Public Law 92–463, Proposed Flood Hazard applications. notice is hereby given that the Determinations Place: National Institutes of Health LD30, Substance Abuse and Mental Health Services Administration’s (SAMHSA) AGENCY: Federal Emergency 5601 Fishers Lane, Rockville, MD 20892. Center for Substance Abuse Prevention’s Management Agency, DHS. Contact Person: Julio Aliberti, Ph.D., Scientific Review Officer, Scientific Review (CSAP) Drug Testing Advisory Board ACTION: Notice. Program, DEA/NIAID/NIH/DHHS, 5601 (DTAB) will convene via web SUMMARY: Comments are requested on Fishers Lane, MSC–9823, Rockville, MD conference on August 8, 2018, from 9:00 proposed flood hazard determinations, 20852, 301–761–7322, alibertijc@ a.m. EDT to 5:00 p.m. EDT. which may include additions or niaid.nih.gov. The board will meet in closed-session modifications of any Base Flood Name of Committee: National Institute of via web conference on August 8, 2018, Elevation (BFE), base flood depth, Allergy and Infectious Diseases Special from 9:00 a.m. EDT to 5:00 p.m. EDT to Special Flood Hazard Area (SFHA) Emphasis Panel; Maintaining Immunity after discuss the proposed Mandatory boundary or zone designation, or Immunization (U01). regulatory floodway on the Flood Guidelines for Federal Workplace Drug Date: July 11–12, 2018. Insurance Rate Maps (FIRMs), and Testing Programs (hair specimens). Time: 8:30 a.m. to 2:00 p.m. where applicable, in the supporting Agenda: To review and evaluate grant Therefore, the meeting is closed to the public as determined by the Assistant Flood Insurance Study (FIS) reports for applications. Secretary for Mental Health and the communities listed in the table Place: National Institutes of Health, 5601 Substance Use, SAMHSA, in accordance below. The purpose of this notice is to Fishers Lane, Rockville, MD 20892. with 5 U.S.C. 552b(c)(4) and (9)(B), and seek general information and comment Contact Person: Geetanjali Bansal, Ph.D., 5 U.S.C. App. 2, Section 10(d). regarding the preliminary FIRM, and Scientific Reviewer Officer, Scientific Review where applicable, the FIS report that the Program, Division of Extramural Activities, Meeting registration information can Room 3G49, National Institutes of Health/ Federal Emergency Management Agency be completed at http://snacregister. (FEMA) has provided to the affected NIAID, 5601 Fishers Lane, MSC 9834, samhsa.gov/MeetingList.aspx. Web Bethesda, MD 20892–9834, (240) 669–5073, communities. The FIRM and FIS report conference and call information will be are the basis of the floodplain geetanjali.bansal@nih.gov. sent after completing registration. management measures that the Name of Committee: National Institute of Meeting information and a roster of community is required either to adopt Allergy and Infectious Diseases Special DTAB members may be obtained by or to show evidence of having in effect Emphasis Panel; NIAID INVESTIGATOR accessing the SAMHSA Advisory in order to qualify or remain qualified INITIATED PROGRAM PROJECT (P01). Committees website, http:// for participation in the National Flood Date: July 11, 2018. www.samhsa.gov/about-us/advisory- Insurance Program (NFIP). In addition, Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant councils/drug-testing-advisory-board- the FIRM and FIS report, once effective, applications. dtab or by contacting the Designated will be used by insurance agents and Place: National Institutes of Health, 5601 Federal Officer, CAPT Sean J. Belouin, others to calculate appropriate flood Fishers Lane, Rockville, MD 20892, USPHS. insurance premium rates for new (Telephone Conference Call). buildings and the contents of those Committee Name: Substance Abuse Contact Person: Raymond R. Schleef, buildings. and Mental Health Services Ph.D., Senior Scientific Review Officer, Administration’s Drug Testing Advisory DATES: Comments are to be submitted Scientific Review Program, Division of Board. on or before September 17, 2018. Extramural Activities, Room 3E61, National ADDRESSES: The Preliminary FIRM, and Institutes of Health/NIAID, 5601 Fishers Dates/Time/Type: August 8, 2018, from 9:00 a.m. to 5:00 p.m. EDT: where applicable, the FIS report for Lane, MSC 9823, Bethesda, MD 20892–9823, each community are available for (240) 669–5019, schleefrr@niaid.nih.gov. CLOSED. inspection at both the online location (Catalogue of Federal Domestic Assistance Place: Web Conference. https://www.fema.gov/preliminaryflood Program Nos. 93.855, Allergy, Immunology, Contact: CAPT Sean J. Belouin, hazarddata and the respective and Transplantation Research; 93.856, USPHS, Senior Pharmacology and Community Map Repository address Microbiology and Infectious Diseases listed in the tables below. Additionally, Regulatory Policy Advisor, Division of Research, National Institutes of Health, HHS) the current effective FIRM and FIS Workplace Programs, 5600 Fishers Lane, Dated: June 13, 2018. Room 16N06D, Rockville, Maryland report for each community are Natasha M. Copeland, 20857, Telephone: (240) 276–2600, accessible online through the FEMA Email: sean.belouin@samhsa.hhs.gov. Map Service Center at https:// daltland on DSKBBV9HB2PROD with NOTICES Program Analyst, Office of Federal Advisory Committee Policy. msc.fema.gov for comparison. Carlos Castillo, You may submit comments, identified [FR Doc. 2018–13138 Filed 6–18–18; 8:45 am] Committee Management Officer, SAMHSA. by Docket No. FEMA–B–1830, to Rick BILLING CODE 4140–01–P [FR Doc. 2018–13116 Filed 6–18–18; 8:45 am] Sacbibit, Chief, Engineering Services BILLING CODE 4162–20–P Branch, Federal Insurance and Mitigation Administration, FEMA, 400 C Street SW, Washington, DC 20472, VerDate Sep<11>2014 17:55 Jun 18, 2018 Jkt 244001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1


Document Created: 2018-07-02 11:21:42
Document Modified: 2018-07-02 11:21:42
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 9-10, 2018.
FR Citation83 FR 28431 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR